Lyophilized injectable drugs market to reach $4.87 billion by 2030 at 4.2% CAGR, driven by rising incidence of cardiac disorders.
Read More
Lymphocyte activating gene 3 (lag3) antibody market to reach $1.53 billion by 2030 at 13.9% CAGR, driven by rising cancer incidence.
Read More
Lyme disease vaccine market to reach $1.57 billion by 2030 at 7.0% CAGR, driven by increasing prevalence of lyme disease and rising healthcare expenditure.
Read More
Lung cancer drugs market to reach $88.06 billion by 2030 at 10.9% CAGR, driven by rising prevalence rate of lung cancer.
Read More
Lumbosacral radicular pain management market to reach $1.17 billion by 2030 at 5.4% CAGR, driven by rising prevalence of back pain disorders.
Read More
Lumbosacral radicular pain market to reach $1.28 billion by 2030 at 5.7% CAGR, driven by increasing prevalence of degenerative spinal conditions and rising prevalence of obesity.
Read More
Losartan potassium active pharmaceutical ingredient (api) market to reach $2.54 billion by 2030 at 6.5% CAGR, driven by growing prevalence of hypertension.
Read More
Local anesthesia drugs market to reach $6.15 billion by 2030 at 5.6% CAGR, driven by increase in prevalence of chronic diseases.
Read More
Liver health supplements market to reach $14.82 billion by 2030 at 6.3% CAGR, driven by rising consumption of alcohol and increasing prevalence of chronic liver diseases.
Read More
Liver cancer therapeutics market to reach $6.34 billion by 2030 at 16.5% CAGR, driven by rise in incidence of hepatitis b infections.
Read More